Exploring the genetics of Epstein-Barr Virus (EBV) and its effects on the human genome.
Official title: EBV Genomics and Bioinformatics
Funded at Wistar Institute · NIH-11085176 · Data updated 2026-11-12
This study is looking at how the Epstein-Barr Virus (EBV) interacts with our genes to help us understand it better, which could lead to improved treatments for conditions related to EBV, and it's designed to help patients like you.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wistar Institute NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | May 11, 2023 |
| Project end | April 30, 2028 |
| Funding year | 2025 |
| Award (this year) | $210,134 |
| NIH project number | 5P01CA269043-03 |
| Project ID | NIH-11085176 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals with conditions linked to Epstein-Barr Virus or those interested in genetic studies related to viral infections.
✕Less likely to help
Patients without any connection to Epstein-Barr Virus or related conditions may not receive any benefit from this research.
What this research studies
This research focuses on understanding the Epstein-Barr Virus (EBV) through advanced genomic techniques and bioinformatics. It aims to develop methods to analyze both viral and human genomes using next-generation sequencing technologies. Patients may benefit from insights gained about how EBV interacts with human genetics, potentially leading to better understanding and treatment of EBV-related conditions. The research will also provide support for data management and analysis across various projects related to EBV.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and management of diseases associated with Epstein-Barr Virus.
How similar studies have gone: Previous research has shown success in using genomic approaches to study viral interactions with host genomes, indicating a promising avenue for this investigation.
Where this research is happening
-
Wistar Institute
Philadelphia, United States Active
Researchers
- Principal investigator: Tempera, Italo — Wistar Institute
- Study coordinator: Tempera, Italo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.